zolbetuximab
astellas
[]
positive study of zolbetuximab (claudin 18.2 ab) plus folfox for 1st line treatment in claudin expressing stage iv gastroesophageal cancer - shitara et al spotlight trial lba292 #gi23 
GI medical oncologist, Associate Prof Univ of WI, public health, proud Midwesterner, opinions mine  FCOI: https://t.co/vHScVEaG0b